Last update 08 May 2025

Yttrium[90Y] carbosphere

Overview

Basic Info

Drug Type
Small molecule drug, Therapeutic radiopharmaceuticals
Synonyms
Target-
Action-
Mechanism
Ionising radiation emitters
Therapeutic Areas
NeoplasmsDigestive System Disorders
Active Indication
Unresectable Hepatocellular CarcinomaColorectal Cancer
Inactive Indication-
Originator Organization
Chengdu New Radiomedicine Technology Co.,Ltd.Chengdu New Radiomedicine Technology Co.,Ltd.
Active Organization
Chengdu New Radiomedicine Technology Co.,Ltd.Chengdu New Radiomedicine Technology Co.,Ltd.
Inactive Organization-
License Organization-
Drug Highest PhasePhase 3
First Approval Date-
Regulation-
Login to view timeline

Related

4
Clinical Trials associated with Yttrium[90Y] carbosphere
NCT06900543
/ RecruitingPhase 3
A Randomized, Open-label, Multicenter Study Comparing the Efficacy and Safety of NRT6003 Injection With Conventional Transarterial Chemoembolization (cTACE) in Chinese Patients With Unresectable Hepatocellular Carcinoma (HCC)
NCT06310590
/ Active, not recruitingPhase 1
Study on the Safety and Effectiveness of NRT6003 Injection in Patients with Unresectable Hepatocellular Carcinoma (HCC)
NCT05957640
/ RecruitingPhase 1IIT
Yttrium-90 Carbon Microspheres in Patients With Unresectable Hepatocellular Carcinoma: A Multicentre, Prospective, Open-label, Single-arm Trial
100 Clinical Results associated with Yttrium[90Y] carbosphere
Login to view more data
100 Translational Medicine associated with Yttrium[90Y] carbosphere
Login to view more data
100 Patents (Medical) associated with Yttrium[90Y] carbosphere
Login to view more data
100 Deals associated with Yttrium[90Y] carbosphere
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Unresectable Hepatocellular CarcinomaPhase 3
China
Chengdu New Radiomedicine Technology Co.,Ltd.Chengdu New Radiomedicine Technology Co.,Ltd.
15 Apr 2025
Colorectal CancerPhase 1
China
Chengdu New Radiomedicine Technology Co.,Ltd.Chengdu New Radiomedicine Technology Co.,Ltd.
30 Dec 2022
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free